Medidata Reaches New 52-Week High (MDSO)

NEW YORK ( TheStreet) -- Medidata Solutions (Nasdaq: MDSO) hit a new 52-week high Wednesday as it is currently trading at $29.69, above its previous 52-week high of $29.65 with 75,212 shares traded as of 10:48 a.m. ET. Average volume has been 170,900 shares over the past 30 days.

Medidata has a market cap of $707.6 million and is part of the technology sector and computer software & services industry. Shares are up 32.3% year to date as of the close of trading on Tuesday.

Medidata Solutions, Inc. provides software-as-a-service based clinical development solutions for life science organizations worldwide. The company has a P/E ratio of 17.3, equal to the average computer software & services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Medidata as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Medidata Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

If you liked this article you might like

Insider Trading Alert - MDSO, BDN And COBZ Traded By Insiders

Stock To Watch: Medidata Solutions (MDSO) In Perilous Reversal

Medidata Solutions (MDSO) Is Strong On High Volume Today

Insider Trading Alert - MDSO, ATEN And MDRX Traded By Insiders

Insider Trading Alert - MDSO, KAI And VVUS Traded By Insiders